Skip to main content
Top
Published in: Abdominal Radiology 10/2019

01-10-2019 | Spleen

Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noise

Authors: Cheng William Hong, Gavin Hamilton, Catherine Hooker, Charlie C. Park, Calvin Andrew Tran, Walter C. Henderson, Jonathan C. Hooker, Soudabeh Fazeli Dehkordy, Jeffrey B. Schwimmer, Scott B. Reeder, Claude B. Sirlin

Published in: Abdominal Radiology | Issue 10/2019

Login to get access

Abstract

Purpose

This study compares splenic proton density fat fraction (PDFF) measured using confounder-corrected chemical shift-encoded (CSE)-MRI to magnetic resonance spectroscopy (MRS) in human patients at 3T.

Methods

This was a prospectively designed ancillary study to various previously described single-center studies performed in adults and children with known or suspected nonalcoholic fatty liver disease. Patients underwent magnitude-based MRI (MRI-M), complex-based MRI (MRI-C), high signal-to-noise variants (Hi-SNR MRI-M and Hi-SNR MRI-C), and MRS at 3T for spleen PDFF estimation. PDFF from CSE-MRI methods were compared to MRS-PDFF using Wilcoxon signed-rank tests. Demographics were summarized descriptively. Spearman’s rank correlations were computed pairwise between CSE-MRI methods. Individual patient measurements were plotted for qualitative assessment. A significance level of 0.05 was used.

Results

Forty-seven patients (20 female, 27 male) including 12 adults (median 55 years old) and 35 children (median 12 years old). Median PDFF estimated by MRS, MRI-M, Hi-SNR MRI-M, MRI-C, and Hi-SNR MRI-C was 1.0, 2.3, 1.9, 2.2, and 2.0%. The four CSE-MRI methods estimated statistically significant higher spleen PDFF values compared to MRS (p < 0.0001 for all). Pairwise associations in spleen PDFF values measured by different CSE-MRI methods were weak, with the highest Spearman’s rank correlations being 0.295 between MRI-M and Hi-SNR MRI-M; none were significant after correction for multiple comparisons. No qualitative relationship was observed between PDFF measurements among the various methods.

Conclusion

Overestimation of PDFF by CSE-MRI compared to MRS and poor agreement between related CSE-MRI methods suggest that non-zero PDFF values in human spleen are artifactual.
Literature
1.
go back to reference Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34(4):729–749.CrossRefPubMedPubMedCentral Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34(4):729–749.CrossRefPubMedPubMedCentral
2.
go back to reference Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging. 2012;36(5):1011–1014.CrossRefPubMedPubMedCentral Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging. 2012;36(5):1011–1014.CrossRefPubMedPubMedCentral
3.
go back to reference Meisamy S, Hines CDG, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011;258(3):767–775.CrossRefPubMedPubMedCentral Meisamy S, Hines CDG, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011;258(3):767–775.CrossRefPubMedPubMedCentral
4.
go back to reference Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology. 2011;258(3):749–759. Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology. 2011;258(3):749–759.
5.
go back to reference Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251(1):67–76. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251(1):67–76.
6.
go back to reference Hernando D, Sharma SD, Aliyari Ghasabeh M, et al. Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom. Magn Reson Med. 2016 Hernando D, Sharma SD, Aliyari Ghasabeh M, et al. Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom. Magn Reson Med. 2016
8.
go back to reference Cassidy FH, Yokoo T, Aganovic L, et al. Fatty Liver Disease: MR Imaging Techniques for the Detection and Quantification of Liver Steatosis. RadioGraphics. Radiological Society of North America; 2009;29(1):231–260. Cassidy FH, Yokoo T, Aganovic L, et al. Fatty Liver Disease: MR Imaging Techniques for the Detection and Quantification of Liver Steatosis. RadioGraphics. Radiological Society of North America; 2009;29(1):231–260.
9.
go back to reference İdilman İS, Gümrük F, Haliloğlu M, Karçaaltıncaba M. The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload. Turkish J Haematol Off J Turkish Soc Haematol. Galenos Yayinevi; 2016;33(1):21–27. İdilman İS, Gümrük F, Haliloğlu M, Karçaaltıncaba M. The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload. Turkish J Haematol Off J Turkish Soc Haematol. Galenos Yayinevi; 2016;33(1):21–27.
10.
go back to reference Mamidipalli A, Hamilton G, Manning P, et al. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis. J Magn Reson Imaging. 2018;47(2):418–424.CrossRefPubMed Mamidipalli A, Hamilton G, Manning P, et al. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis. J Magn Reson Imaging. 2018;47(2):418–424.CrossRefPubMed
11.
go back to reference Loomba R, Sirlin CB, Ang B, et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology. 2015;61(4):1239–1250.CrossRefPubMedPubMedCentral Loomba R, Sirlin CB, Ang B, et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology. 2015;61(4):1239–1250.CrossRefPubMedPubMedCentral
12.
go back to reference Cui J, Philo L, Nguyen P, et al. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. J Hepatol. 2016;65(2):369–376. Cui J, Philo L, Nguyen P, et al. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. J Hepatol. 2016;65(2):369–376.
13.
go back to reference Doycheva I, Cui J, Nguyen P, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther. NIH Public Access; 2016;43(1):83–95. Doycheva I, Cui J, Nguyen P, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther. NIH Public Access; 2016;43(1):83–95.
14.
go back to reference Loomba R, Seguritan V, Li W, et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017;25(5):1054–1062.e5.CrossRefPubMedPubMedCentral Loomba R, Seguritan V, Li W, et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017;25(5):1054–1062.e5.CrossRefPubMedPubMedCentral
15.
go back to reference Motosugi U, Hernando D, Wiens C, Bannas P, Reeder SB. High SNR Acquisitions Improve the Repeatability of Liver Fat Quantification Using Confounder-corrected Chemical Shift-encoded MR Imaging. Magn Reson Med Sci. 2017 Motosugi U, Hernando D, Wiens C, Bannas P, Reeder SB. High SNR Acquisitions Improve the Repeatability of Liver Fat Quantification Using Confounder-corrected Chemical Shift-encoded MR Imaging. Magn Reson Med Sci. 2017
16.
go back to reference Hamilton G, Yokoo T, Bydder M, et al. In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed. 2011;24(7):784–790.CrossRefPubMed Hamilton G, Yokoo T, Bydder M, et al. In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed. 2011;24(7):784–790.CrossRefPubMed
17.
go back to reference Kühn J-P, Hernando D, Mensel B, et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging. 2014;39(6):1494–1501.CrossRefPubMed Kühn J-P, Hernando D, Mensel B, et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging. 2014;39(6):1494–1501.CrossRefPubMed
18.
go back to reference Bydder M, Yokoo T, Hamilton G, et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging. 2008;26(3):347–359.CrossRefPubMedPubMedCentral Bydder M, Yokoo T, Hamilton G, et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging. 2008;26(3):347–359.CrossRefPubMedPubMedCentral
19.
go back to reference Hernando D, Hines CDG, Yu H, Reeder SB. Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method. Magn Reson Med. NIH Public Access; 2012;67(3):638–644. Hernando D, Hines CDG, Yu H, Reeder SB. Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method. Magn Reson Med. NIH Public Access; 2012;67(3):638–644.
20.
go back to reference Yu H, Shimakawa A, Hines CDG, et al. Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med. 2011;66(1):199–206.CrossRefPubMedPubMedCentral Yu H, Shimakawa A, Hines CDG, et al. Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med. 2011;66(1):199–206.CrossRefPubMedPubMedCentral
21.
go back to reference Kühn J-P, Jahn C, Hernando D, et al. T1 bias in chemical shift-encoded liver fat-fraction: Role of the flip angle. J Magn Reson Imaging. 2014;40(4):875–883.CrossRefPubMed Kühn J-P, Jahn C, Hernando D, et al. T1 bias in chemical shift-encoded liver fat-fraction: Role of the flip angle. J Magn Reson Imaging. 2014;40(4):875–883.CrossRefPubMed
22.
go back to reference Johnson BL, Schroeder ME, Wolfson T, et al. Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson Imaging. 2014;39(2):440–447.CrossRefPubMed Johnson BL, Schroeder ME, Wolfson T, et al. Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson Imaging. 2014;39(2):440–447.CrossRefPubMed
23.
go back to reference Reeder SB, Pineda AR, Wen Z, et al. Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn Reson Med. 2005;54(3):636–644.CrossRefPubMed Reeder SB, Pineda AR, Wen Z, et al. Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn Reson Med. 2005;54(3):636–644.CrossRefPubMed
24.
go back to reference Reeder SB, McKenzie CA, Pineda AR, et al. Water–fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging. 2007;25(3):644–652.CrossRefPubMed Reeder SB, McKenzie CA, Pineda AR, et al. Water–fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging. 2007;25(3):644–652.CrossRefPubMed
25.
go back to reference Reeder SB, Wen Z, Yu H, et al. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med. 2004;51(1):35–45.CrossRefPubMed Reeder SB, Wen Z, Yu H, et al. Multicoil Dixon chemical species separation with an iterative least-squares estimation method. Magn Reson Med. 2004;51(1):35–45.CrossRefPubMed
26.
go back to reference Hernando D, Haldar JP, Sutton BP, Ma J, Kellman P, Liang Z-P. Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med. 2008;59(3):571–580.CrossRefPubMedPubMedCentral Hernando D, Haldar JP, Sutton BP, Ma J, Kellman P, Liang Z-P. Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med. 2008;59(3):571–580.CrossRefPubMedPubMedCentral
27.
go back to reference Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med. NIH Public Access; 2008;60(5):1122–1134. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med. NIH Public Access; 2008;60(5):1122–1134.
28.
go back to reference Hamilton G, Middleton MS, Hooker JC, et al. In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence. J Magn Reson Imaging. 2015;42(6):1538–1543.CrossRefPubMedPubMedCentral Hamilton G, Middleton MS, Hooker JC, et al. In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence. J Magn Reson Imaging. 2015;42(6):1538–1543.CrossRefPubMedPubMedCentral
30.
go back to reference Vanhamme, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129(1):35–43. Vanhamme, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129(1):35–43.
31.
go back to reference Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12(2–3):141–152.CrossRefPubMed Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12(2–3):141–152.CrossRefPubMed
32.
go back to reference Haufe WM, Wolfson T, Hooker CA, et al. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference. J Magn Reson Imaging. 2017 Haufe WM, Wolfson T, Hooker CA, et al. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference. J Magn Reson Imaging. 2017
33.
go back to reference Bashir MR, Huang R, Mayes N, et al. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging. 2015;42(2):305–314.CrossRefPubMed Bashir MR, Huang R, Mayes N, et al. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging. 2015;42(2):305–314.CrossRefPubMed
34.
go back to reference Karlsson M, Ekstedt M, Dahlström N, et al. Liver R2* is affected by both iron and fat: A dual biopsy-validated study of chronic liver disease. J Magn Reson Imaging. 2019 Karlsson M, Ekstedt M, Dahlström N, et al. Liver R2* is affected by both iron and fat: A dual biopsy-validated study of chronic liver disease. J Magn Reson Imaging. 2019
35.
go back to reference Roberts NT, Hernando D, Holmes JH, Wiens CN, Reeder SB. Noise properties of proton density fat fraction estimated using chemical shift-encoded MRI. Magn Reson Med. 2018;80(2):685–695.CrossRefPubMedPubMedCentral Roberts NT, Hernando D, Holmes JH, Wiens CN, Reeder SB. Noise properties of proton density fat fraction estimated using chemical shift-encoded MRI. Magn Reson Med. 2018;80(2):685–695.CrossRefPubMedPubMedCentral
36.
go back to reference Liu C-Y, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med. 2007;58(2):354–364.CrossRefPubMed Liu C-Y, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med. 2007;58(2):354–364.CrossRefPubMed
37.
go back to reference Colgan TJ, Hernando D, Sharma SD, Reeder SB. The effects of concomitant gradients on chemical shift encoded MRI. Magn Reson Med. 2017;78(2):730–738.CrossRefPubMed Colgan TJ, Hernando D, Sharma SD, Reeder SB. The effects of concomitant gradients on chemical shift encoded MRI. Magn Reson Med. 2017;78(2):730–738.CrossRefPubMed
38.
go back to reference Yokoo T, Serai SD, Pirasteh A, et al. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology. 2017;170550. Yokoo T, Serai SD, Pirasteh A, et al. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology. 2017;170550.
39.
go back to reference Nasr P, Forsgren MF, Ignatova S, et al. Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis. Gastroenterology. 2017;153(1):53–55.e7.CrossRefPubMed Nasr P, Forsgren MF, Ignatova S, et al. Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis. Gastroenterology. 2017;153(1):53–55.e7.CrossRefPubMed
40.
go back to reference Idilman IS, Tuzun A, Savas B, et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging. 2015;40(6):1512–1519.CrossRefPubMed Idilman IS, Tuzun A, Savas B, et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging. 2015;40(6):1512–1519.CrossRefPubMed
41.
Metadata
Title
Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noise
Authors
Cheng William Hong
Gavin Hamilton
Catherine Hooker
Charlie C. Park
Calvin Andrew Tran
Walter C. Henderson
Jonathan C. Hooker
Soudabeh Fazeli Dehkordy
Jeffrey B. Schwimmer
Scott B. Reeder
Claude B. Sirlin
Publication date
01-10-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02079-z

Other articles of this Issue 10/2019

Abdominal Radiology 10/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.